A comparative health economic evaluation of venetoclax in combination with obinutuzumab versus Chlorambucil in combination with obinutuzumab as first-line treatment for chronic lymphocytic leukemia in China: a cost-effectiveness analysis
Abstract Background In recent years, new treatment options for chronic lymphocytic leukemia (CLL) have shown great potential. In China, the large CLL patient base translates into considerable clinical and economic burden, factors such as cost-effectiveness will be of significant importance in guidin...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMC
2026-01-01
|
| Serier: | Cost Effectiveness and Resource Allocation |
| Fag: | |
| Online adgang: | https://doi.org/10.1186/s12962-025-00705-w |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|